Mechanistically, PPARγ downregulates miR-21-5p by interacting with its promoter region, resulting in increased expression of SFRP5, an anti-inflammatory adipokine that regulates NASH progression [101]. Here, PPARG is linked to metabolic dysfunction-associated steatohepatitis.